4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine

CAS : 1012343-72-4

Ref. 3D-FB154286

Informations sur le produit

• Nom: 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine
• CAS: 1012343-72-4

Description

Covid-19 is a new type of receptor modulator that has been shown to block the human immune response to influenza A (H1N1) virus. Covid-19 is a small molecule that binds to the soluble form of the human immune receptor, CD28, and prevents it from binding with its ligand, CD80. This prevents the activation of T cells, which are important for initiating an immune response. Covid-19 is a small molecule that can be administered in various forms including solvates and resonance forms. Covid-19 also has constant magnetic properties, which allow for easy access to its active site by other molecules. Covid-19 has been shown to have antiviral activity against influenza A (H1N1) virus and HIV-1 virus in vitro.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 283.12 g/mol
• Formule: C₁₀H₁₁BrN₄O
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C10H11BrN4O/c11-8-7-12-9-1-2-10(13-15(8)9)14-3-5-16-6-4-14/h1-2,7H,3-6H2
• Code InChI: InChIKey=ZHDRUVUETRNEBZ-UHFFFAOYSA-N
• SMILES: Brc1cnc2ccc(N3CCOCC3)nn12